Oscar Health Inc. Announces $350 Million Convertible Senior Subordinated Notes Offering, with Option for Additional $52.5 Million
Oscar Health Inc. has announced its intention to offer $350,000,000 aggregate principal amount of convertible senior subordinated notes due 2030 in a private offering to qualified investors. The New York-based company also expects to grant initial purchasers an option to buy an additional $52,500,000 aggregate principal amount of notes, potentially increasing the total value of the issuance. The interest rate, initial conversion rate, and other terms of the notes will be determined at the pricing of the offering. Oscar intends to use the proceeds for general corporate purposes, including strategic AI initiatives and member experience enhancements. Additionally, part of the proceeds will be used to fund capped call transactions to offset share dilution.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oscar Health Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250915647303) on September 15, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。